Ray Dalio’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $854K | Sell |
11,303
-2,145
| -16% | -$161K | ﹤0.01% | 813 |
|
|
2025
Q4 | $1M | Sell |
13,448
-10,124
| -43% | -$740K | ﹤0.01% | 885 |
|
|
2025
Q3 | $1.59M | Buy |
23,572
+16,258
| +222% | +$1.08M | 0.01% | 779 |
|
|
2025
Q2 | $477K | Sell |
7,314
-24,557
| -77% | -$1.47M | ﹤0.01% | 522 |
|
|
2025
Q1 | $1.97M | Sell |
31,871
-21,926
| -41% | -$1.45M | 0.01% | 449 |
|
|
2024
Q4 | $3.88M | Sell |
53,797
-111,030
| -67% | -$8.67M | 0.02% | 378 |
|
|
2024
Q3 | $13.4M | Sell |
164,827
-152,507
| -48% | -$12.2M | 0.08% | 218 |
|
|
2024
Q2 | $23.6M | Buy |
317,334
+8,091
| +3% | +$607K | 0.12% | 138 |
|
|
2024
Q1 | $24.1M | Sell |
309,243
-115,093
| -27% | -$8.56M | 0.12% | 128 |
|
|
2023
Q4 | $30.3M | Sell |
424,336
-96,857
| -19% | -$6.74M | 0.17% | 102 |
|
|
2023
Q3 | $36.2M | Buy |
521,193
+33,381
| +7% | +$2.52M | 0.22% | 86 |
|
|
2023
Q2 | $39.5M | Sell |
487,812
-56,579
| -10% | -$4.62M | 0.24% | 78 |
|
|
2023
Q1 | $43.9M | Buy |
544,391
+98,331
| +22% | +$7.92M | 0.27% | 72 |
|
|
2022
Q4 | $33.4M | Sell |
446,060
-153,339
| -26% | -$10.9M | 0.18% | 107 |
|
|
2022
Q3 | $38.7M | Sell |
599,399
-39,235
| -6% | -$2.72M | 0.2% | 104 |
|
|
2022
Q2 | $44.3M | Buy |
638,634
+246,407
| +63% | +$18.3M | 0.19% | 108 |
|
|
2022
Q1 | $30.1M | Buy |
392,227
+90,017
| +30% | +$6.47M | 0.12% | 128 |
|
|
2021
Q4 | $23.1M | Buy |
302,210
+16,128
| +6% | +$1.19M | 0.13% | 117 |
|
|
2021
Q3 | $21.1M | Sell |
286,082
-23,667
| -8% | -$1.77M | 0.12% | 125 |
|
|
2021
Q2 | $20.7M | Buy |
309,749
+129,050
| +71% | +$8.63M | 0.13% | 125 |
|
|
2021
Q1 | $13.4M | Buy |
180,699
+25,978
| +17% | +$1.97M | 0.12% | 135 |
|
|
2020
Q4 | $11.3M | Buy |
154,721
+90,375
| +140% | +$6.38M | 0.1% | 112 |
|
|
2020
Q3 | $4.28M | Buy |
+64,346
| New | +$4.07M | 0.05% | 156 |
|
|
2019
Q1 | – | Sell |
-34,277
| Closed | -$1.41M | – | 396 |
|
|
2018
Q4 | $1.41M | Buy |
+34,277
| New | +$1.41M | 0.01% | 292 |
|
|
2018
Q2 | – | Sell |
-20,164
| Closed | -$753K | – | 492 |
|
|
2018
Q1 | $753K | Buy |
+20,164
| New | +$815K | 0.01% | 351 |
|
|
2016
Q2 | – | Sell |
-52,900
| Closed | -$1.82M | – | 354 |
|
|
2016
Q1 | $1.82M | Buy |
+52,900
| New | +$1.84M | 0.02% | 195 |
|
|
2013
Q3 | – | Sell |
-43,800
| Closed | -$845K | – | 350 |
|
|
2013
Q2 | $845K | Buy |
+43,800
| New | +$915K | 0.01% | 205 |
|
Other funds holding HOLX
VCM
HI
VPM
Ray Dalio's HOLX Position: Q1 2026 in Review
Ray Dalio reduced its Hologic (HOLX) stake by 16% in Q1 2026, selling an estimated $161K and leaving 11,303 shares worth $854K. The position accounts for ﹤0.01% of the portfolio, ranked #813.
Ray Dalio first reported a position in HOLX in Q2 2013 and has held it in 27 quarters since. The position peaked at $44.3M in Q2 2022. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.
- Ray Dalio held 11,303 shares of Hologic worth $854K as of Q1 2026.
- Ray Dalio sold 2,145 Hologic shares in Q1 2026, an estimated $161K.
- Hologic made up ﹤0.01% of Ray Dalio's portfolio in Q1 2026, its #813 holding.
- Ray Dalio first reported a position in Hologic in Q2 2013 and has held it in 27 quarters since.
- Ray Dalio's Hologic position peaked at $44.3M in Q2 2022.
- 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.
Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.